A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080)
Clinical trial NCT04447755 · COMPLETED
Trial details
- NCT number
- NCT04447755
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-30
- Primary completion
- 2022-09-16
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.